Abstract
Few topics in neurology have generated as much recent debate as the use of biomarkers in prediction of cognitive decline and dementia in cognitively normal individuals. Since substantial brain damage has already occurred by the time a clinical diagnosis of dementia is made, this may be too late for any effective intervention. Inflammatory markers have been identified as potentially useful biomarkers in predicting and monitoring progression of cognitive decline until dementia.1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
